{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T19:27:20Z","timestamp":1783711640999,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"AFMU Science and Technology Project on Major Medical Problems","award":["2023JSYX30"],"award-info":[{"award-number":["2023JSYX30"]}]},{"name":"AFMU Science and Technology Project on Major Medical Problems","award":["2023KXKT028"],"award-info":[{"award-number":["2023KXKT028"]}]},{"name":"AFMU Science and Technology Project on Major Medical Problems","award":["2023JSYX01"],"award-info":[{"award-number":["2023JSYX01"]}]},{"name":"AFMU Postdoctoral Lanjian Foundation","award":["lj20230202"],"award-info":[{"award-number":["lj20230202"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82203733"],"award-info":[{"award-number":["No.82203733"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82203510"],"award-info":[{"award-number":["No. 82203510"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82203733"],"award-info":[{"award-number":["No.82203733"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Research and Development Program of Shaanxi Province","award":["2023-YBSF-273"],"award-info":[{"award-number":["2023-YBSF-273"]}]},{"name":"Key Research and Development Program of Shaanxi Province","award":["2023-YBSF-198"],"award-info":[{"award-number":["2023-YBSF-198"]}]},{"name":"Medical Key Project of Xi'an","award":["No.24YSYJ0005"],"award-info":[{"award-number":["No.24YSYJ0005"]}]},{"name":"Youth promotion project of Xi'an","award":["No.959202313100"],"award-info":[{"award-number":["No.959202313100"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00430-024-00811-1","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T02:27:05Z","timestamp":1732760825000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Construction and evaluation of glycoprotein-based nucleic acid vaccines for Marburg virus"],"prefix":"10.1007","volume":"214","author":[{"given":"Xiyang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiming","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirui","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanli","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuya","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongbo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"issue":"5","key":"811_CR1","doi-asserted-by":"publisher","first-page":"e307","DOI":"10.1016\/s1473-3099(23)00515-7","volume":"24","author":"G Cuomo-Dannenburg","year":"2024","unstructured":"Cuomo-Dannenburg G, McCain K, McCabe R, Unwin HJT, Doohan P, Nash RK et al (2024) Marburg virus disease outbreaks, mathematical models, and disease parameters: a systematic review. Lancet Infect Dis 24(5):e307\u2013e17. https:\/\/doi.org\/10.1016\/s1473-3099(23)00515-7","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"811_CR2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1080\/21505594.2022.2054760","volume":"13","author":"MH Abir","year":"2022","unstructured":"Abir MH, Rahman T, Das A, Etu SN, Nafiz IH, Rakib A et al (2022) Pathogenicity and virulence of Marburg virus. Virulence 13(1):609\u2013633. https:\/\/doi.org\/10.1080\/21505594.2022.2054760","journal-title":"Virulence"},{"key":"811_CR3","doi-asserted-by":"publisher","first-page":"1239079","DOI":"10.3389\/fmicb.2023.1239079","volume":"14","author":"S Srivastava","year":"2023","unstructured":"Srivastava S, Sharma D, Kumar S, Sharma A, Rijal R, Asija A et al (2023) Emergence of Marburg virus: a global perspective on fatal outbreaks and clinical challenges. Front Microbiol 14:1239079. https:\/\/doi.org\/10.3389\/fmicb.2023.1239079","journal-title":"Front Microbiol"},{"issue":"1","key":"811_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5334\/aogh.4178","volume":"90","author":"KN Ezie","year":"2024","unstructured":"Ezie KN, Takoutsing BD, Modeste D, Ines MZ, Sybile TNL, Caleb NM et al (2024) Marburg Virus Outbreak in Equatorial Guinea: need for speed. Annals Global Health 90(1):5. https:\/\/doi.org\/10.5334\/aogh.4178","journal-title":"Annals Global Health"},{"issue":"5","key":"811_CR5","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/s1473-3099(23)00221-9","volume":"23","author":"U Samarasekera","year":"2023","unstructured":"Samarasekera U (2023) Marburg virus outbreak in Equatorial Guinea. Lancet Infect Dis 23(5):534. https:\/\/doi.org\/10.1016\/s1473-3099(23)00221-9","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"811_CR6","doi-asserted-by":"publisher","first-page":"e280223214111","DOI":"10.2174\/1871526523666230228103845","volume":"23","author":"S Ashique","year":"2023","unstructured":"Ashique S, Chaudhary V, Pal S, Panwar J, Kumar M, Pramanik S et al (2023) Marburg Virus- A threat during SARS-CoV-2 era: a review. Infect Disord Drug Targ 23(5):e280223214111. https:\/\/doi.org\/10.2174\/1871526523666230228103845","journal-title":"Infect Disord Drug Targ"},{"issue":"1","key":"811_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41541-022-00503-y","volume":"7","author":"T Travieso","year":"2022","unstructured":"Travieso T, Li J, Mahesh S, Mello J, Blasi M (2022) The use of viral vectors in vaccine development. NPJ Vaccines 7(1):75. https:\/\/doi.org\/10.1038\/s41541-022-00503-y","journal-title":"NPJ Vaccines"},{"issue":"23","key":"811_CR8","doi-asserted-by":"publisher","first-page":"168297","DOI":"10.1016\/j.jmb.2023.168297","volume":"435","author":"S Pagliari","year":"2023","unstructured":"Pagliari S, Dema B, Sanchez-Martinez A, Montalvo Zurbia-Flores G, Rollier CS (2023) DNA vaccines: history, Molecular mechanisms and Future perspectives. J Mol Biol 435(23):168297. https:\/\/doi.org\/10.1016\/j.jmb.2023.168297","journal-title":"J Mol Biol"},{"issue":"3\u20134","key":"811_CR9","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/milmed\/usac129","volume":"188","author":"AT Biggs","year":"2023","unstructured":"Biggs AT, Littlejohn LF (2023) Describing mRNA Vaccine Technology for a military audience. Mil Med 188(3\u20134):547\u2013554. https:\/\/doi.org\/10.1093\/milmed\/usac129","journal-title":"Mil Med"},{"issue":"6","key":"811_CR10","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1093\/nar\/gkaa070","volume":"48","author":"CJC Parr","year":"2020","unstructured":"Parr CJC, Wada S, Kotake K, Kameda S, Matsuura S, Sakashita S et al (2020) N 1-Methylpseudouridine substitution enhances the performance of synthetic mRNA switches in cells. Nucleic Acids Res 48(6):e35. https:\/\/doi.org\/10.1093\/nar\/gkaa070","journal-title":"Nucleic Acids Res"},{"issue":"51","key":"811_CR11","doi-asserted-by":"publisher","first-page":"e2303261","DOI":"10.1002\/adma.202303261","volume":"35","author":"Y Zong","year":"2023","unstructured":"Zong Y, Lin Y, Wei T, Cheng Q (2023) Lipid nanoparticle (LNP) enables mRNA delivery for Cancer Therapy. Adv Mater (Deerfield Beach Fla) 35(51):e2303261. https:\/\/doi.org\/10.1002\/adma.202303261","journal-title":"Adv Mater (Deerfield Beach Fla)"},{"key":"811_CR12","doi-asserted-by":"publisher","first-page":"120586","DOI":"10.1016\/j.ijpharm.2021.120586","volume":"601","author":"L Schoenmaker","year":"2021","unstructured":"Schoenmaker L, Witzigmann D, Kulkarni JA, Verbeke R, Kersten G, Jiskoot W et al (2021) mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability. Int J Pharm 601:120586. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120586","journal-title":"Int J Pharm"},{"issue":"5","key":"811_CR13","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/j.ymthe.2022.02.001","volume":"30","author":"H Muramatsu","year":"2022","unstructured":"Muramatsu H, Lam K, Bajusz C, Laczk\u00f3 D, Karik\u00f3 K, Schreiner P et al (2022) Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine. Mol Therapy: J Am Soc Gene Therapy 30(5):1941\u20131951. https:\/\/doi.org\/10.1016\/j.ymthe.2022.02.001","journal-title":"Mol Therapy: J Am Soc Gene Therapy"},{"issue":"16","key":"811_CR14","doi-asserted-by":"publisher","first-page":"8188","DOI":"10.1128\/jvi.00453-11","volume":"85","author":"E Mittler","year":"2011","unstructured":"Mittler E, Kolesnikova L, Hartlieb B, Davey R, Becker S (2011) The cytoplasmic domain of Marburg virus GP modulates early steps of viral infection. J Virol 85(16):8188\u20138196. https:\/\/doi.org\/10.1128\/jvi.00453-11","journal-title":"J Virol"},{"issue":"5","key":"811_CR15","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.cell.2015.01.041","volume":"160","author":"T Hashiguchi","year":"2015","unstructured":"Hashiguchi T, Fusco ML, Bornholdt ZA, Lee JE, Flyak AI, Matsuoka R et al (2015) Structural basis for Marburg virus neutralization by a cross-reactive human antibody. Cell 160(5):904\u2013912. https:\/\/doi.org\/10.1016\/j.cell.2015.01.041","journal-title":"Cell"},{"key":"811_CR16","doi-asserted-by":"publisher","first-page":"105141","DOI":"10.1016\/j.antiviral.2021.105141","volume":"193","author":"Y Liu","year":"2021","unstructured":"Liu Y, Sun B, Pan J, Feng Y, Ye W, Xu J et al (2021) Construction and evaluation of DNA vaccine encoding Ebola virus glycoprotein fused with lysosome-associated membrane protein. Antiviral Res 193:105141. https:\/\/doi.org\/10.1016\/j.antiviral.2021.105141","journal-title":"Antiviral Res"},{"key":"811_CR17","doi-asserted-by":"publisher","unstructured":"Zhang J, Sun B, Shen W, Wang Z, Liu Y, Sun Y et al (2023) In Silico Analyses, Experimental Verification and Application in DNA vaccines of Ebolavirus GP-Derived pan-MHC-II-Restricted epitopes. Vaccines 11(10). https:\/\/doi.org\/10.3390\/vaccines11101620","DOI":"10.3390\/vaccines11101620"},{"issue":"6","key":"811_CR18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/intimm\/dxac006","volume":"34","author":"Y Liu","year":"2022","unstructured":"Liu Y, Sun B, Wang J, Sun H, Lu Z, Chen L et al (2022) In silico analyses and experimental validation of the MHC class-I restricted epitopes of Ebolavirus GP. Int Immunol 34(6):313\u2013325. https:\/\/doi.org\/10.1093\/intimm\/dxac006","journal-title":"Int Immunol"},{"issue":"1","key":"811_CR19","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/s2666-5247(22)00258-0","volume":"4","author":"Y Araf","year":"2023","unstructured":"Araf Y, Maliha ST, Zhai J, Zheng C (2023) Marburg virus outbreak in 2022: a public health concern. Lancet Microbe 4(1):e9. https:\/\/doi.org\/10.1016\/s2666-5247(22)00258-0","journal-title":"Lancet Microbe"},{"issue":"8","key":"811_CR20","doi-asserted-by":"publisher","first-page":"829","DOI":"10.6026\/97320630019829","volume":"19","author":"JT Sinnott","year":"2023","unstructured":"Sinnott JT, Kim K, Somboonwit C, Cosnett C, Segal D, Shapshak P (2023) Emergent Risk Group-4 (RG-4) filoviruses: a paradox in progress. Bioinformation 19(8):829\u2013832. https:\/\/doi.org\/10.6026\/97320630019829","journal-title":"Bioinformation"},{"issue":"7","key":"811_CR21","doi-asserted-by":"publisher","first-page":"e1395","DOI":"10.1002\/hsr2.1395","volume":"6","author":"I Ahmed","year":"2023","unstructured":"Ahmed I, Salsabil L, Hossain MJ, Shahriar M, Bhuiyan MA, Islam MR (2023) The recent outbreaks of Marburg virus disease in African countries are indicating potential threat to the global public health: future prediction from historical data. Health Sci Rep 6(7):e1395. https:\/\/doi.org\/10.1002\/hsr2.1395","journal-title":"Health Sci Rep"},{"issue":"1","key":"811_CR22","first-page":"13","volume":"39","author":"GM Ignat\u2019ev","year":"1994","unstructured":"Ignat\u2019ev GM, Strel\u2019tsova MA, Agafonov AP, Zhukova NA, Kashentseva EA (1994) Vorob\u2019Eva MS. [The immunity indices of animals immunized with the inactivated Marburg virus after infection with homologous virus]. Vopr Virusol 39(1):13\u201317","journal-title":"Vopr Virusol"},{"issue":"25\u201326","key":"811_CR23","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.1016\/s0264-410x(03)00362-1","volume":"21","author":"J Riemenschneider","year":"2003","unstructured":"Riemenschneider J, Garrison A, Geisbert J, Jahrling P, Hevey M, Negley D et al (2003) Comparison of individual and combination DNA vaccines for B. Anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus. Vaccine 21(25\u201326):4071\u20134080. https:\/\/doi.org\/10.1016\/s0264-410x(03)00362-1","journal-title":"Vaccine"},{"issue":"19","key":"811_CR24","doi-asserted-by":"publisher","first-page":"10386","DOI":"10.1128\/jvi.00594-10","volume":"84","author":"TW Geisbert","year":"2010","unstructured":"Geisbert TW, Bailey M, Geisbert JB, Asiedu C, Roederer M, Grazia-Pau M et al (2010) Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburg virus in nonhuman primates. J Virol 84(19):10386\u201310394. https:\/\/doi.org\/10.1128\/jvi.00594-10","journal-title":"J Virol"},{"issue":"4","key":"811_CR25","doi-asserted-by":"publisher","first-page":"e94355","DOI":"10.1371\/journal.pone.0094355","volume":"9","author":"CE Mire","year":"2014","unstructured":"Mire CE, Geisbert JB, Agans KN, Satterfield BA, Versteeg KM, Fritz EA et al (2014) Durability of a vesicular stomatitis virus-based marburg virus vaccine in nonhuman primates. PLoS ONE 9(4):e94355. https:\/\/doi.org\/10.1371\/journal.pone.0094355","journal-title":"PLoS ONE"},{"issue":"1","key":"811_CR26","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12985-017-0869-3","volume":"14","author":"W Gai","year":"2017","unstructured":"Gai W, Zheng X, Wang C, Wang H, Zhao Y, Wang Q et al (2017) Marburg virus-like particles by co-expression of glycoprotein and matrix protein in insect cells induces immune responses in mice. Virol J 14(1):204. https:\/\/doi.org\/10.1186\/s12985-017-0869-3","journal-title":"Virol J"},{"issue":"10373","key":"811_CR27","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/s0140-6736(22)02400-x","volume":"401","author":"MJ Hamer","year":"2023","unstructured":"Hamer MJ, Houser KV, Hofstetter AR, Ortega-Villa AM, Lee C, Preston A et al (2023) Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial. Lancet (London England) 401(10373):294\u2013302. https:\/\/doi.org\/10.1016\/s0140-6736(22)02400-x","journal-title":"Lancet (London England)"},{"key":"811_CR28","doi-asserted-by":"publisher","unstructured":"Liu MA (2019) A comparison of plasmid DNA and mRNA as Vaccine technologies. Vaccines 7(2). https:\/\/doi.org\/10.3390\/vaccines7020037","DOI":"10.3390\/vaccines7020037"},{"issue":"10332","key":"811_CR29","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/s0140-6736(22)00151-9","volume":"399","author":"A Khobragade","year":"2022","unstructured":"Khobragade A, Bhate S, Ramaiah V, Deshpande S, Giri K, Phophle H et al (2022) Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India. Lancet (London England) 399(10332):1313\u20131321. https:\/\/doi.org\/10.1016\/s0140-6736(22)00151-9","journal-title":"Lancet (London England)"},{"issue":"9977","key":"811_CR30","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/s0140-6736(14)62385-0","volume":"385","author":"H Kibuuka","year":"2015","unstructured":"Kibuuka H, Berkowitz NM, Millard M, Enama ME, Tindikahwa A, Sekiziyivu AB et al (2015) Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial. Lancet (London England) 385(9977):1545\u20131554. https:\/\/doi.org\/10.1016\/s0140-6736(14)62385-0","journal-title":"Lancet (London England)"},{"issue":"8","key":"811_CR31","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1080\/21645515.2015.1039757","volume":"11","author":"RJ Grant-Klein","year":"2015","unstructured":"Grant-Klein RJ, Altamura LA, Badger CV, Bounds CE, Van Deusen NM, Kwilas SA et al (2015) Codon-optimized filovirus DNA vaccines delivered by intramuscular electroporation protect cynomolgus macaques from lethal Ebola and Marburg virus challenges. Hum Vaccines Immunotherapeutics 11(8):1991\u20132004. https:\/\/doi.org\/10.1080\/21645515.2015.1039757","journal-title":"Hum Vaccines Immunotherapeutics"},{"issue":"4","key":"811_CR32","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi N, Hogan MJ, Porter FW, Weissman D (2018) mRNA vaccines - a new era in vaccinology. Nat Rev Drug Discovery 17(4):261\u2013279. https:\/\/doi.org\/10.1038\/nrd.2017.243","journal-title":"Nat Rev Drug Discovery"},{"issue":"6","key":"811_CR33","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s10238-023-01020-5","volume":"23","author":"Y Mei","year":"2023","unstructured":"Mei Y, Wang X (2023) RNA modification in mRNA cancer vaccines. Clin Experimental Med 23(6):1917\u20131931. https:\/\/doi.org\/10.1007\/s10238-023-01020-5","journal-title":"Clin Experimental Med"},{"key":"811_CR34","doi-asserted-by":"publisher","first-page":"5560605","DOI":"10.1155\/2023\/5560605","volume":"2023","author":"FF Albaqami","year":"2023","unstructured":"Albaqami FF, Altharawi A, Althurwi HN, Alharthy KM, Qasim M, Muhseen ZT et al (2023) Computational modeling and evaluation of potential mRNA and peptide-based vaccine against Marburg Virus (MARV) to provide Immune Protection against Hemorrhagic Fever. Biomed Res Int 2023:5560605. https:\/\/doi.org\/10.1155\/2023\/5560605","journal-title":"Biomed Res Int"},{"issue":"7","key":"811_CR35","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nm1258","volume":"11","author":"SM Jones","year":"2005","unstructured":"Jones SM, Feldmann H, Str\u00f6her U, Geisbert JB, Fernando L, Grolla A et al (2005) Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med 11(7):786\u2013790. https:\/\/doi.org\/10.1038\/nm1258","journal-title":"Nat Med"},{"issue":"1","key":"811_CR36","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41541-020-00226-y","volume":"5","author":"DC Malherbe","year":"2020","unstructured":"Malherbe DC, Domi A, Hauser MJ, Meyer M, Gunn BM, Alter G et al (2020) Modified vaccinia Ankara vaccine expressing Marburg virus-like particles protects guinea pigs from lethal Marburg virus infection. NPJ Vaccines 5(1):78. https:\/\/doi.org\/10.1038\/s41541-020-00226-y","journal-title":"NPJ Vaccines"},{"key":"811_CR37","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-4087897\/v1","author":"A Bukreyev","year":"2024","unstructured":"Bukreyev A, Meyer M, Gunn B, Pietzsch C, Subramani C, Saphire E et al (2024) Divergent antibody recognition profiles are generated by protective mRNA vaccines against Marburg and Ravn viruses. Res Square. https:\/\/doi.org\/10.21203\/rs.3.rs-4087897\/v1","journal-title":"Res Square"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-024-00811-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00430-024-00811-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-024-00811-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T11:56:35Z","timestamp":1767095795000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00430-024-00811-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["811"],"URL":"https:\/\/doi.org\/10.1007\/s00430-024-00811-1","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]},"assertion":[{"value":"2 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}